Early Biological Fixation of Porous Implant Coated With Paste-Retaining Recombinant Bone Morphogenetic Protein 2

Journal of Arthroplasty

Volumn 27, Issue 1, 2012, Pages

  Fukunaga, Kenji ^a   Minoda, Yukihide ^a   Iwakiri, Kentaro ^a,b   Iwaki, Hiroyoshi ^a   Nakamura, Hiroaki ^a   Takaoka, Kunio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Shirahama Hamayu Hospital   (Japan)

Author keywords

Biodegradable polymer; BMP 2; Implant fixation

Indexed keywords

CALCIUM PHOSPHATE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MARROW; CONTROLLED STUDY; FEMALE; IMPLANT; NONHUMAN;

EID: 83555164951     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.06.017     Document Type: Article

References (32)

1. Mäkelä K.T., Eskelinen A., Pulkkinen P., et al. Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry. J Bone Joint Surg Am 2008, 90:2160.
2. Michael J.A., Jonathan W.S., Steven C.S., et al. Cementless total hip arthroplasty in patients 50 years or younger. J Arthroplasty 2006, 21:476.
3. Gabbar O.A., Rajan R.A., Londhe S., et al. Ten- to twelve-year follow-up of the furlong hydroxyapatite-coated femoral stem and threaded acetabular cup in patients younger than 65 years. J Arthroplasty 2008, 23:413.
4. Baek S.H., Kim S.Y. Cementless total hip arthroplasty with alumina bearings in patients younger than fifty with femoral head osteonecrosis. J Bone Joint Surg Am 2008, 90:1314.
5. Bojescul J.A., Xenos J.S., Callaghan J.J., et al. Results of porous-coated anatomic total hip arthroplasty without cement at fifteen years: a concise follow-up of a previous report. J Bone Joint Surg Am 2003, 85:1079.
6. Belmont P.J., Powers C.C., Beykirch S.E., et al. Results of the anatomic medullary locking total hip arthroplasty at a minimum of twenty years. A concise follow-up of previous reports. J Bone Joint Surg Am 2008, 90:1524.
7. Freeman M.A., Plante-Bordeneuve P Early migration and late aseptic failure of proximal femoral prostheses. J Bone Joint Surg Br 1994, 76:432.
8. Lombardi A.V., Berend K.R., Mallory T.H., et al. Survivorship of 2000 tapered titanium porous plasma-sprayed femoral components. Clin Orthop Relat Res 2009, 467:146.
9. Rajaratnam S.S., Jack C., Tavakkolizadeh A., et al. Long-term results of a hydroxyapatite-coated femoral component in total hip replacement: a 15- to 21-year follow-up study. J Bone Joint Surg Br 2008, 90:27.
10. Suratwala S.J., Cho S.K., Van Raalte J.J., et al. Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite. J Bone Joint Surg Am 2008, 90:2189.
11. Wozney J.M., Rosen V., Celeste A.J., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528.
12. Wang E.A., Rosen V., D'Alessandro J.S., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990, 87:2220.
13. Takaoka K., Yoshikawa H., Hasimoto J., et al. Gene cloning and expression of a bone morphogenetic protein derived from a murine osteosarcoma. Clin Orthop Relat Res 1993, 294:344.
14. Takaoka K., Yoshikawa H., Hashimoto J., et al. Purification and characterization of a bone-inducing protein from a murine osteosarcoma (Dunn type). Clin Orthop Relat Res 1993, 292:329.
15. Namikawa T., Terai H., Hoshino M., et al. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model. Spine 2007, 32:2294.
16. Namikawa T., Terai H., Suzuki E., et al. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model. Spine 2005, 30:1717.
17. Boden S.D., Kang J., Sandhu H., et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002, 27:2662.
18. Akamaru T., Suh D., Boden S.D., et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003, 28:429.
19. Sachse A., Wagner A., Keller M., et al. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 2005, 37:699.
20. Fujisawa A., Noda I., Nishio Y., et al. The development of new titanium arc-sprayed artificial joints. Materials Science and Engineering 1995, 151.
21. Frost H.M. Preparation of thin undercalcified bone sections by rapid manual method. Stain Technol 1958, 33:272.
22. Wikesjö U.M., Huang Y., Xiropaidis A.V., et al. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (type IV bone) in non-human primates. J Clin Periodontol 2008, 35:992.
23. Sykaras N., Triplett R., Nunn M.E., et al. Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res 2001, 12:339.
24. Jovanovic S.A., Hunt D.R., Bernard G.W., et al. Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003, 14:793.
25. Yamaji K., Kawanami M., Matsumoto A., et al. Effects of dose of recombinant human BMP-2 on bone formation at palatal sites in young and old rats. Dent Mater J 2007, 26:481.
26. Valentin-Opran A., Wozney J., Csimma C., et al. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 2002, 395:110.
27. Nishida S., Endo N., Yamagiwa H., et al. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab 1999, 17:171.
28. Sumner D.R., Turner T.M., Urban R.M., et al. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 2004, 22:58.
29. McClellan J.W., Mulconrey D.S., Forbes R.J., et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006, 19:483.
30. Kanatani M., Sugimoto T., Kaji H., et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 1995, 10:1681.
31. Saito N., Takaoka K. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials 2003, 24:2287.
32. Kato M., Namikawa T., Terai H., et al. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2. Biomaterials 2006, 27:3927.